News

UC Riverside study could lead to new treatments addressing multiple sclerosis

UC Riverside-led mouse study stresses MS treatment should be started early

UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...

UC Riverside-led study shows that ‘good inflammation’ promotes axon myelination